<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ijms-20-02118-t004" orientation="portrait" position="float" class="table-wrap">
 <object-id pub-id-type="pii" class="object-id">ijms-20-02118-t004_Table 4</object-id>
 <label class="label">Table 4</label>
 <caption class="caption">
  <p class="p">LCPUFAsâ€™ impact on DMR regions in human controlled trials.</p>
 </caption>
 <table frame="hsides" rules="groups" class="table">
  <thead class="thead">
   <tr class="tr">
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Population</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Genes Involved</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Biological Function </th>
   </tr>
  </thead>
  <tbody class="tbody">
   <tr class="tr">
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">Greek adolescents with different fat dietary intake [
     <xref rid="B89-ijms-20-02118" ref-type="bibr" class="xref">89</xref>]
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">
     <italic class="italic">NCOA1</italic>, 
     <italic class="italic">PDE3A</italic>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">susceptibility to diet-induced obesity, leptin pathway</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">Newborns from DHA-supplemented pregnant women in Mexico [
     <xref rid="B92-ijms-20-02118" ref-type="bibr" class="xref">92</xref>]
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">
     <italic class="italic">IGF2</italic>
     <italic class="italic">P3</italic>
     <italic class="italic">H19</italic>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">fetal growth, development, and metabolism</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">Children of DHA-supplemented pregnant women (at birth and at 5 years) [
     <xref rid="B93-ijms-20-02118" ref-type="bibr" class="xref">93</xref>]
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">
     <italic class="italic">ESYT3</italic>, 
     <italic class="italic">SLC12A6</italic>, 
     <italic class="italic">CCK</italic>, 
     <italic class="italic">RAET1L</italic>, 
     <italic class="italic">LTB</italic>
    </td>
    <td align="center" valign="middle" rowspan="1" colspan="1" class="td">lipid membrane exchange, plasma membrane function, appetite regulation, immune function, neurodevelopment</td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DHA-supplemented overweight and obese adults in Canada [
     <xref rid="B91-ijms-20-02118" ref-type="bibr" class="xref">91</xref>]
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <italic class="italic">AKT3</italic>, 
     <italic class="italic">PTEN</italic>, 
     <italic class="italic">BAX</italic>, etc. 
     <italic class="italic">IGFBP5</italic>, 
     <italic class="italic">KLK6</italic>, etc. 
     <italic class="italic">PRKAG2</italic>, 
     <italic class="italic">PRKCZ</italic>, 
     <italic class="italic">HDAC4</italic>, 
     <italic class="italic">PRKAG2</italic>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">immune response lipid metabolism type 2 diabetes CV signaling</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
